Approval
TGA approves first pharma option for proliferative diabetic retinopathy
For 40 years laser therapy has been the standard treatment for proliferative diabetic retinopathy (PDR), but now Australian ophthalmologists have ...
TGA approves ‘breakthrough’ B+L contact lens
Bausch + Lomb has obtained regulatory approval to supply its new Ultra One Day daily disposable silicone hydrogel (SiHy daily) ...
New dry eye therapy now TGA-approved
Australian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye. Cequa (ciclosporin 900 microgram/mL) ...
Novartis AMD drug Beovu secures European approval
European drug regulators have followed in the footsteps of their Australian and US counterparts, following the approval of Novartis’ new ...
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the ...
Hoya secures ‘VIP status’ for Australian border checks
Australian border officials have granted Hoya Lens Australia a special status that will reduce red tape and smooth the supply ...
CooperVision’s MiSight receives FDA approval, to launch in 2020
CooperVision has received clearance from the US Food and Drug Administration (FDA) for its MiSight 1 Day Contact Lens for ...